Ambrilia Biopharma, Inc.

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 66.7

EPO Patents = 2

Forward Citations = 54

Loading Chart...

13 inventors (with patents filed for the assignee):

Brent Richard Stranix (4 out of 20 patents)

Valérie Perron (2 out of 9 patents)

Guy Milot (2 out of 7 patents)

4. Jean-Marc Sabatier (1 out of 7 patents)

5. Jean-Emmanuel Bouchard (1 out of 3 patents)

6. Stephane Branchaud (1 out of 2 patents)

7. Pierre Du Ruisseau (1 out of 5 patents)

8. Kamel Mabrouk (1 out of 5 patents)

9. Herve Rochat (1 out of 4 patents)

10. Jonathan Reeves (1 out of 1 patent)

11. Edward Jerome Tanner (1 out of 1 patent)

12. Jurphaas Van Rietschoten (1 out of 3 patents)

13. Chandra J Panchal (1 out of 4 patents)

14. Abderrahim Bouzide (16 patents)

15. Gilles Sauve (2 patents)

6 patents: Sort by Forward Citations

1. 8283366 - Derivatives of pyridoxine for inhibiting HIV integrase (2012-10-09),

2. 8227450 - Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation (2012-07-24),

3. 8008297 - Lysine based compounds (2011-08-30),

4. 7534580 - PSP94 diagnostic reagents and assays (2009-05-19),

5. 7388008 - Lysine based compounds (2008-06-17),

6. 7285621 - Multiple branch peptide construction (2007-10-23),

Company Overview

Ambrilia Biopharma is a biotechnology company focused on the development of novel therapeutics in the areas of oncology, infectious diseases and dermatology. With a strong pipeline of innovative drugs and a commitment to advancing healthcare, Ambrilia is dedicated to improving the lives of patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#172 in Montreal

#2,421 in Canada

Montreal, Canada

Ambrilia Biopharma, Inc.

Forward Citations = 54

13 inventors:

Brent Richard Stranix (4 out of 20 patents)

Valérie Perron (2 out of 9 patents)

Guy Milot (2 out of 7 patents)

4. Jean-Marc Sabatier (1 out of 7 patents)

5. Jean-Emmanuel Bouchard (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ambrilia Biopharma, Inc.. Retrieved from https://idiyas.com/company/ambrilia-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]